Pitcairn CO Eli Lilly & CO Transaction History

Pitcairn CO

$1.63 Billion
Q1 2025

A detailed history of Pitcairn CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Pitcairn CO holds 8,832 shares of LLY stock, worth $6.41 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

8,832

Previous 8,688 1.66%

Holding current value

$6.41 Million

Previous $6.71 Million 8.75%

% of portfolio

0.45%

Previous 0.4%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$725.72 - $929.72 $104,503 - $133,879	144 Added 1.66%	8,832 $7.29 Million
Q4 2024 Feb 12, 2025	SELL	$727.2 - $932.06 $175,255 - $224,626	-241 Reduced 2.7%	8,688 $6.71 Million
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $479,498 - $596,172	-621 Reduced 6.5%	8,929 $7.91 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $431,297 - $540,878	595 Added 6.64%	9,550 $8.65 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $183,582 - $245,606	-310 Reduced 3.35%	8,955 $6.97 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $9,978 - $11,763	-19 Reduced 0.2%	9,265 $5.4 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $732,904 - $1.01 Million	1,686 Added 22.19%	9,284 $4.99 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $1,052 - $1,406	-3 Reduced 0.04%	7,598 $3.56 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $149,102 - $175,113	480 Added 6.74%	7,601 $2.61 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $20,579 - $23,978	-64 Reduced 0.89%	7,121 $2.61 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $275,133 - $313,543	-928 Reduced 11.44%	7,185 $2.32 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $357,331 - $419,560	1,282 Added 18.77%	8,113 $2.63 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $101,855 - $126,580	-434 Reduced 5.97%	6,831 $1.96 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $142,779 - $177,190	635 Added 9.58%	7,265 $2.01 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $99,941 - $122,992	451 Added 7.3%	6,630 $1.53 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $193,007 - $249,654	-1,069 Reduced 14.75%	6,179 $1.42 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $412,771 - $534,352	-2,512 Reduced 25.74%	7,248 $1.35 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $171,946 - $227,526	-1,318 Reduced 11.9%	9,760 $1.65 Million
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $140,517 - $162,533	-961 Reduced 7.98%	11,078 $1.64 Million
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $5,456 - $6,567	40 Added 0.33%	12,039 $1.98 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $830,611 - $1.03 Million	6,977 Added 138.93%	11,999 $1.67 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $16,893 - $20,923	-158 Reduced 3.05%	5,022 $661,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $518,465 - $563,956	-4,855 Reduced 48.38%	5,180 $580,000
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $245,067 - $286,055	-2,212 Reduced 18.06%	10,035 $1.11 Million
Q1 2019 May 07, 2019	BUY	$111.31 - $131.02 $161,733 - $190,372	1,453 Added 13.46%	12,247 $1.59 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $641,859 - $719,077	6,061 Added 128.06%	10,794 $1.25 Million
Q3 2018 Nov 02, 2018	BUY	$85.86 - $107.31 $59,243 - $74,043	690 Added 17.07%	4,733 $508,000
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $13,626 - $15,638	-180 Reduced 4.26%	4,043 $345,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $40,221 - $47,479	-542 Reduced 11.37%	4,223 $327,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $12,454 - $13,359	152 Added 3.3%	4,765 $403,000
Q3 2017 Nov 03, 2017	BUY	$77.07 - $85.54 $355,523 - $394,596	4,613	4,613 $394,000

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $689B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account